Using Medication Level Variability to Predict Posttransplant Risk
Eyal Shemesh – 10 February 2021
Eyal Shemesh – 10 February 2021
Najib Ben Khaled, Daniel Roessler, Florian P. Reiter, Max Seidensticker, Markus Guba, Enrico N. De Toni – 10 February 2021
Emily Harding‐Theobald, Francis Y.K. Yao, Neil Mehta – 10 February 2021 – We assessed the prognostic significance and the clinical stability of the neutrophil‐to‐lymphocyte ratio (NLR) before liver transplantation (LT) in a large cohort of patients with hepatocellular carcinoma (HCC) from a region with a long waitlist time. A high preoperative NLR ≥5 has been reported to predict poor outcomes following LT for HCC, and the NLR has been incorporated into several prognostic models.
Ninh Quoc Dat, Le Thi Thanh Thuy, Vu Ngoc Hieu, Hoang Hai, Dinh Viet Hoang, Nguyen Thi Thanh Hai, Tuong Thi Van Thuy, Tohru Komiya, Krista Rombouts, Minh Phuong Dong, Ngo Vinh Hanh, Truong Huu Hoang, Misako Sato‐Matsubara, Atsuko Daikoku, Chiho Kadono, Daisuke Oikawa, Katsutoshi Yoshizato, Fuminori Tokunaga, Massimo Pinzani, Norifumi Kawada – 10 February 2021
This live webinar will focus on identifying areas of unmet needs and developing a research career. We will have four presenters share their career experiences. An experienced professional will share her experience on doing clinical research in hepatitis B and thoughts on selecting between research, quality improvement or medical educator.
Prashant Bhangui – 9 February 2021
Rianne A. Weersink, Kelly L. Hayward – 8 February 2021
Michael Schonfeld, Maria T. Villar, Antonio Artigues, Steven A. Weinman, Irina Tikhanovich – 8 February 2021 – Protein arginine methyl transferase 1 (PRMT1) is the main enzyme for cellular arginine methylation. It regulates many aspects of liver biology including inflammation, lipid metabolism, and proliferation. Previously we identified that PRMT1 is necessary for protection from alcohol‐induced liver injury. However, many PRMT1 targets in the liver after alcohol exposure are not yet identified.
Antti Kyrönlahti, Nimish Godbole, Oyediran Akinrinade, Tea Soini, Iiris Nyholm, Noora Andersson, Maria Hukkinen, Jouko Lohi, David B. Wilson, Marjut Pihlajoki, Mikko P. Pakarinen, Markku Heikinheimo – 8 February 2021 – Successful portoenterostomy (SPE) improves the short‐term outcome of patients with biliary atresia (BA) by relieving cholestasis and extending survival with native liver. Despite SPE, hepatic fibrosis progresses in most patients, leading to cirrhosis and a deterioration of liver function.
Dennis Warner, Vatsalya Vatsalya, Kara H. Zirnheld, Jeffrey B. Warner, Josiah E. Hardesty, John C. Umhau, Craig J. McClain, Krishnarao Maddipati, Irina A. Kirpich – 8 February 2021 – Alcohol‐associated liver disease (ALD) is a spectrum of liver disorders ranging from steatosis to steatohepatitis, fibrosis, and cirrhosis. Alcohol‐associated hepatitis (AH) is an acute and often severe form of ALD with substantial morbidity and mortality. The mechanisms and mediators of ALD progression and severity are not well understood, and effective therapeutic options are limited.